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Abstract
The multi-functional NS1 protein of influenza A virus is a viral virulence determining factor. The last four residues at the C-
terminus of NS1 constitute a type I PDZ domain binding motif (PBM). Avian influenza viruses currently in circulation carry an
NS1 PBM with consensus sequence ESEV, whereas human influenza viruses bear an NS1 PBM with consensus sequence
RSKV or RSEV. The PBM sequence of the influenza A virus NS1 is reported to contribute to high viral pathogenicity in animal
studies. Here, we report the identification of PDlim2 as a novel binding target of the highly pathogenic avian influenza virus
H5N1 strain with an NS1 PBM of ESEV (A/Chicken/Henan/12/2004/H5N1, HN12-NS1) by yeast two-hybrid screening. The
interaction was confirmed by in vitro GST pull-down assays, as well as by in vivo mammalian two-hybrid assays and
bimolecular fluorescence complementation assays. The binding was also confirmed to be mediated by the interaction of the
PDlim2 PDZ domain with the NS1 PBM motif. Interestingly, our assays showed that PDlim2 bound specifically with HN12-
NS1, but exhibited no binding to NS1 from a human influenza H1N1 virus bearing an RSEV PBM (A/Puerto Rico/8/34/H1N1,
PR8-NS1). A crystal structure of the PDlim2 PDZ domain fused with the C-terminal hexapeptide from HN12-NS1, together
with GST pull-down assays on PDlim2 mutants, reveals that residues Arg16 and Lys31 of PDlim2 are critical for the binding
between PDlim2 and HN12-NS1. The identification of a selective binding target of HN12-NS1 (ESEV), but not PR8-NS1 (RSEV),
enables us to propose a structural mechanism for the interaction between NS1 PBM and PDlim2 or other PDZ-containing
proteins.
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Introduction
The influenza A virus has long posed a threat to human health.
The avian influenza H5N1 virus exhibits significantly higher
pathogenicity than other strains, with nearly 60% lethality in
human infections (WHO, 2010). Previous studies have shown that
pigs infected with a recombinant human H1N1 influenza virus in
which the NS1 gene is replaced with that from the H5N1 strain
experienced significantly more serious fever, weight loss and
viremia than those infected by the wild-type human influenza
H1N1 virus [1]. The NS1 protein was consequently identified as
an important factor determining the virulence of the influenza
virus. As a multifunctional protein, NS1 predominantly impacts
host immune response during viral infection by reducing the
induction of IFN-b [2,3], inhibiting the RNA sensor activity of
human retinoic acid-inducible gene product I (RIG-I) [4],
suppressing the dsRNA dependent protein kinase (PKR) induced
protein synthesis termination [5] and limiting the activation of
29-59-oligoadenylate synthase (OAS) [6], as well as disrupting
interferon signaling by reducing the tyrosine phosphorylation of
STAT proteins [7]. Other studies have demonstrated that NS1 is
able to integrate with phosphatidylinositol-3-kinase (PI3K) and
prevent apoptosis during infection [8,9].
Obenauer and colleagues noted that the C-terminal four amino
acids of NS1 constitute a type I PDZ binding motif (PBM) [10,11].
PDZ (PSD-95/Dlg-A/ZO-1) domains contain approximately 80
amino acids and act to mediate interaction with other proteins
[12]. Therefore, PDZ-containing proteins are widely considered to
act as scaffold proteins. Due to their affinity to the cytoskeleton,
they are thought to regulate cell migration, adhesion and polarity
depending on the cellular localization of the protein [13]. In a
previous study, 30 human PDZ-domain-containing proteins were
identified to be able to bind to a PBM with the sequence ESEV,
which is commonly found in the NS1 protein from avian influenza
viruses, including those with the H5N1 subtype [10]. A large scale
analysis demonstrated that 92% of NS1 proteins sourced from
avian influenza viruses contain a PBM bearing the sequence
ESEV, while NS1 proteins sourced from human influenza viruses
mostly bear PBM with the sequence RSKV or RSEV. Only about
8% of human influenza virus NS1 proteins bear a H5N1-like PBM
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high-mortality outbreaks of influenza [10]. A subsequent study
showed that substituting the human NS1 PBM with a PBM
derived from highly pathogenic avian influenza (HPAI) H5N1
viruses (either ESEV or EPEV) did not affect the growth of virus
but significantly increased its virulence and pathogenicity in mice
[14]. Therefore, the NS1 PBM is suspected to be a virulence-
determining ligand in a host- and species-dependent manner
[15,16].
One of the functions of the ESEV PBM was recently
discovered to be in apoptosis limitation during viral infection
via direct interaction with the cellular PDZ-containing protein
Scribble [17]. The relationship between the precise amino acid
composition in the PBM and its binding ability with certain PDZ-
containing proteins has been reported [18]. However, the
detailed structural basis for their interaction remains to be
identified. In this study, we identified PDlim2, another PDZ-
containing protein, as a binding target of NS1 encoded by a
highly pathogenic H5N1 avian influenza virus, A/Chicken/
Henan/12/2004 (HN12-NS1), via the PDZ-PBM interaction in
vitro and at the cell level. We found that the PDZ domain of
PDlim2 binds specifically to the C-terminal PBM sequence ESEV
of HN12-NS1 but not to the NS1 protein from an H1N1 strain,
A/Puerto Rico/8/34 (PR8-NS1), which has a corresponding
PBM sequence of RSEV. Analysis of the crystal structure of the
PDlim2 PDZ domain in complex with the C-terminal hexapep-
tide of HN12-NS1 provides a molecular basis to explain the
binding mechanism and selectivity between the two proteins, and
indicates why PDlim2 binds to HN12-NS1 (ESEV) but barely to
PR8-NS1 (RSEV). This work, although preliminary, provides a
structural basis for the binding selectivity of PDZ-containing
proteins to the ESEV-terminal NS1 of the highly pathogenic
H5N1 strain, and thus leads to further understanding of the me-
chanism for the PDZ-PBM interaction.
Materials and Methods
Cells, Plasmids and Antibodies
HeLa (ATCC:CCL-2) cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum. The plasmid containing the coding sequence of
NS1 of A/Puerto Rico/8/34 /H1N1 (Accession No.:CY009448,
GenBank), pCAGGS-P7-PR8-NS1, and total RNA of H5N1
influenza virus (A/Chicken/Henan/12/2004/H5N1), Accession
No.:AY950260, GenBank) were kindly provided by Z. Chen
(College of Life Sciences, Huhan Normal University, China). For
GST pull-down assays, cDNA encoding NS1s and His-tagged
PDlim2 (Accession No.: AAH21556.1, GenBank) were respective-
ly inserted into pGEX-4T-1 (GE) and pET-28a (Novagen).
PDlim2 mutations were derived from the constructed wild type
PDlim2 plasmid using the Easy Mutagenesis System kit (Trans-
gen). For the two hybridization assays, the commercial vectors,
pGBT9 and pACT2 (Clontech), and pACT, pBind and pG5luc
(Promega) were constructed according to the manufacturer’s
instructions. For purification and crystallization, a DNA fragment
encoding 89 amino acid residues, including the PDlim2 PDZ
domain (residues 1–83) fused with a C-terminal hexapeptide
extension (sequence: TIESEV) corresponding to residues 220–225
of HN12-NS1, was constructed into pGEX-6P-1 (GE Healthcare)
[19,20]. Anti-GST (#2622) and anti-His (sc8036) antibodies were
purchased from Cell Signaling and Santa Cruz, respectively; Anti-
HA (H9658) and anti-Flag (F1804) antibodies were brought
from Sigma; Anti-STAT1 (AHO0832) and anti-phospho-STAT1
(33–3400) were from Invitrogen.
Yeast Two-Hybrid Screening
In yeast two-hybrid assays, pGBT9-HN12-NS1 and pACT2
into which a human spleen library gene was inserted were
transfected into yeast (Y190). After auxotrophic and X-gal double
selection, the plasmids of positive clones were extracted and
sequenced following the protocol in the commercialized kit
(Clontech).
Mammalian Two-Hybrid Assays
pACT-NS1, pBind-PDlim2 and pG5luc were co-transfected into
HeLa cells with a molar ratio of 1:1:1 as suggested (Promega), with
Polyethylenimine (PBI) (1mg/ml) [21,22]. After 48 h, cells were
harvested and lysed, and the firefly and Renilla luciferase activities
were quantified by the Dual-Luciferase Reporter Assay (Promega).
The relative luciferase activity was indicated by the ratio of firefly
to Renilla florescence intensities.
GST Pull-Down Assays
GST-tagged NS1 or associated mutants and His-tagged PDlim2
or associated mutants were expressed in Escherichia coli BL21
(DE3), respectively. The bacterial lysates containing NS1 were
incubated with Glutathione Sepharose 4B (GE) beads with gentle
rolling in lysis buffer (50mM Tris-Cl, 150mM NaCl, 0.5% NP-40
and protease inhibitor cocktail) at 4uC for 1 h. After discarding the
supernatant, the lysate containing His-PDlim2 was added to the
beads and incubated for 2 h with gentle rolling. The resultant
beads were washed with the lysis buffer four times and the eluants
were subjected to SDS-PAGE and Western blot analysis with
antibodies against His-tag and GST respectively.
Bimolecular Fluorescence Complementation (BiFC)
Assays
The BiFC method was adopted to investigate protein binding
in HeLa cells [23]. PDlim2 proteins were fused to the carboxyl-
terminal fragment (YC, aa155–238) of yellow fluorescence protein
(YFP). The HN12-NS1wt or HN12-NS1DPBM coding region was
fused with the N-terminal fragment (YN, aa1–154) of YFP [23].
YC-PDlim2 and the YN-HN12-NS1wt or YN-HN12-NS1DPBM
proteins were co-transfected into HeLa cells grown on glass cover
slips using the PBI method as described above. 24 hours after
transfection, cell culture dishes were transferred to room temper-
ature for 4 hours and stained with 49,6-diamidino-2-phenylindole
(DAPI) prior to microscopic analysis. The fluorescence emission
was examined in living cells by confocal microscopy and images
were processed using an Olympus Fluoview FV1000. The YFP
fluorescence of living cells was also subjected to FACS analysis with
an excitation wavelength at 488 nm and emission wavelength at
513 nm.
Protein Purification and Crystallization
The GST-tagged PDlim2 PDZ domain fused with a C-terminal
hexapeptide extension (sequence: TIESEV) corresponding to
residues 220–225 of HN12-NS1 was expressed in E. coli BL21
(DE3). The harvested bacterial cells were lysed by sonication and
a standard GST affinity purification procedure was performed
using glutathione agarose beads. The GST-tag was removed with
PreScission Protease, and the resultant fusion protein was further
purified with a Superdex 200 10/300 GL gel-filtration column
(GE Healthcare) and condensed at 20 mg/ml concentration in a
buffer composed with 20 mM Tris-Cl (pH 8.0) and 100 mM
NaCl. The protein was crystallized using the sitting drop vapor
diffusion method in 0.1M HEPES (pH 8.2), 0.2 M NaCl, and
22.5% polyethylene glycol (PEG) 3350 at 20uC.
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Diffraction data from the crystals were collected on an in-house
Rigaku MM-007HF X-ray source equipped with an R-AXIS
HTC image plate detector. The diffraction images were integrated
and scaled using HKL2000 [24]. The structure was solved by the
molecular replacement method using the program PHASER [25]
and a native structure of the PDlim2 PDZ domain (1–82), pre-
viously solved in our laboratory (unpublished), as the search
model. The structure was built with the program COOT [26]
and refined with REFMAC5 [27]. Figures were drawn with the
program PYMOL (DeLano Scientific, San Carlos, CA).
Results
Identification of PDlim2 as an HN12-NS1 binding protein
by yeast two-hybrid screening
In order to search for potential functional targets of the in-
fluenza virus NS1 protein, we performed a yeast two-hybrid screen
of a human spleen cDNA library using the HN12-NS1 protein as
bait. After several rounds of panning, we obtained five positive
clones. Sequence analysis of them subsequently identified one of
the clones encoding part of the PDlim2. Based on sequence
alignments, this clone contains a coding region of 238 amino acid
residues, of which residues 1–228 were 100% identical with the N-
terminal of PDlim2. PDlim2 is a protein containing both PDZ and
LIM domains and is reportedly expressed in epithelial cells and
lymphocytes [28,29]. To date, three isoforms of PDlim2 have been
discovered in human cells. The poorly studied isoform 1 has low
transcription levels in lung and is expressed only in the cy-
toskeleton and nucleus [30]. Isoform 3, which is abundant in the
heart and brain [30], lacks the LIM domain (the functional region
of PDlim2) and is also expressed mainly in the cytoskeleton and
nucleus. Previous studies with mouse tissue have indicated that
isoform 2 of PDlim2 is transcribed in the spleen, lymphocyte and
most highly in the lung [30,31], which is considered to be the site
of infection for influenza virus. Therefore, we aimed to explore the
interaction between NS1 and isoform 2 of PDlim2 in all sub-
sequent experiments in this paper.
Verification of the interaction between HN12-NS1 and
PDlim2 via PDZ domain
In order to verify the binding result from the yeast two-hybrid
screening assay, GST pull-down assays were performed using
GST-tagged HN12-NS1 and His-tagged PDlim2. GST-HN12-
NS1 or GST was immobilized with Glutathine-conjugated aga-
rose to pull down His-PDlim2. As shown in Fig. 1A, His-PDlim2
can be detected in the precipitation by GST-HN12-NS1, but not
by GST. The input of lysate containing His-PDlim2 and the
expression of GST or GST-NS1 are shown in the upper panel of
Fig. 1A. This binding assay confirms that HN12-NS1 and PDlim2
interact in vitro. We also repeated the pull-down assay with a
PDlim2 variant in which the PDZ domain was deleted. Figure 1C
shows that the wild-type PDlim2 precipitated HN12-NS1 while
PDlim2DPDZ did not, indicating that the PDZ domain of PDlim2
is required for the interaction with NS1.
To test the intracellular interaction between HN12-NS1 and
PDlim2, we adopted a mammalian two hybrid (M2H) assay
[32,33]. PDlim2 and NS1 (or mutations) were cloned into pBind
and pACT vectors respectively to generate fusion proteins with the
DNA-binding domain (GAL4) or transcription activation domain
(VP16). When co-transfected with the reporter plasmid pG5luc
containing a GAL4 binding site, the positive interactions can be
quantified by firefly luciferase in cells. Renilla luciferase was
expressed by the pBind vector itself for monitoring the transfection
Figure 1. Interaction between PDlim2 and HN12-NS1. (A) GST
pull-down assay. Bacterially expressed GST-HN12-NS1 or GST were pre-
bound to Glutathione conjugated agarose and then incubated with
lysates containing His-PDlim2. The eluates were subjected to SDS-PAGE
and Western blot analyses with anti-His or anti-GST antibodies (left),
and the input proteins in lysates were also analyzed (right). The arrows
indicated the relevant bands. (B) Mammalian two hybrid assay. Reporter
plasmid pG5luc was co-transfected into HeLa cells with a combination
of pACT-or pBind-based constructs as indicated. At 48 h post-
transfection, cells were harvested and firefly (from pG5luc) and renilla
(from pBind) fluorescence unit were measured by luminomitor. The
relative luciferase activity (Y-axis)=the unit of firefly luciferase/the unit
of Renilla luciferase, and is presented as the mean calculated from three
independent experiments. (C) GST pull-down assay for the PDlim2 PDZ
domain deletion mutant (PDlim2-DPDZ) and HN12-NS1. The experi-
ments were performed as described in (A).
doi:10.1371/journal.pone.0019511.g001
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was used as the relative activity unit (RLU) for the binding. As
indicated in Fig. 1B, the reporter luciferase activity reaches 160
RLU (the 5
th bar from left) whereas HN12-NS1 lacking PBM
exhibits only limited reporter activity (the most right bar) as the
negative controls (1–4
th bar from left). The mammalian two hybrid
analysis demonstrated that the binding of HN12-NS1 to PDlim2
occurred intracellularly via its ESEV sequenced PBM. The
deletion of the ESEV PBM of NS1 completely abolished its
binding ability with PDlim2.
To further confirm the interaction in vivo and visualize the
subcellular localization of the binding, we employed more sensitive
bimolecular fluorescence complementation (BiFC) assays [23]. As
described in Materials and Methods, we constructed plasmids
encoding YN-fused HN12-NS1, namely YN-HN12-NS1 wt, or
an NS1 mutant lacking the PBM (YN-HN12-NS1DPBM), as well
as YC fused with PDlim2 (YC-PDlim2), respectively. The pair
of plasmids encoding YN- and YC-fusion proteins were co-
transfected into HeLa cells, and the cells were then examined by
fluorescence microscopy (Fig. 2, left panels) and analyzed by
FACS (Fig. 2, right panels). The interaction indicated by the
generation of YFP signals was only observed in cells transfected
with full-length wild-type HN12-NS1 and PDlim2 (Fig. 2, top
row). An NS1 mutant lacking the PBM exhibited no signal (Fig. 2,
2
nd row from the top), indicating that the PBM of NS1 is required
for interaction with PDlim2. As expected, the control samples with
combinations of the YC or YN fragments and their respective
fusion proteins showed barely detectable YFP signals (Fig. 2, the
bottom three rows). In addition, the interaction of NS1 with
PDlim2 exhibited a punctuate distribution in cytoplasmic space.
The underlying principle of this assay, namely that the N-
terminal (YN) and C-terminal (YC) domains of YFP are brought
into close proximity to form an intact fluorescent protein once
protein binding occurs, allows us to measure the affinity of the
binding partners [23]. In this study, the percentage of cells yielding
fluorescence and the mean fluorescence intensity (MFI) were
determined by FACS analysis, reflecting the binding affinity of
HN12-NS1 and PDlim2. As shown in Fig. 2 (the first two panels
from the right), 10.94% of cells expressing both HN12-NS1wt
and PDlim2 fall into the high fluorescence zone with a mean
florescence intensity (MFI) of 1123.8. In comparison, cells ex-
pressing an HN12-NS1DPBM mutant displayed a low number of
cells with negligible YFP signal, as observed in the control groups
with expression of only one of the effective binding components.
Consistent with the M2H assay results above, the BiFC data
strongly demonstrated that the viral HN12-NS1 protein interacts
with PDlim2 in the cytoplasm, and that the binding is dependent
on the PDZ binding motif of NS1.
PDlim2 binds specifically to HN12-NS1 but not PR8-NS1
The C-terminal PBM of the NS1 protein differs in sequence
between influenza virus strains, and the NS1 protein with ESEV
PBM as commonly found in H5N1 avian influenza viruses is
linked with high pathogenicity [10]. As the only difference
between the two PBMs is the amino acid residue in the 23
position, we therefore ‘‘swapped’’ the PBMs of HN12-NS1 wt and
PR8-NS1 wt by simply mutating the 23 position Arg of PR8-NS1
to a Glu, designated PR8-NS1 (R-3E), and the E (-3) of HN12-
NS1 to Arg, designated HN12-NS1 (E-3R), as shown in Fig. 3A.
GST pull-down assays using these constructs showed that the
HN12-NS1 (E-3R) mutant lost its binding ability to PDlim2
(Fig. 3B, lane 3), whereas the PR8-NS1 (R-3E) mutant acquired
binding ability (Fig. 3B, lane 4) comparable to that of the wild-type
GST-HN12-NS1 wt (Fig. 3B, lane 1). The pull-down by GST
alone was used as a negative control. It was noted that a trace
amount of NS1 was detected in the pull-down assays with wild-
type PR8-NS1 and PR8-NS1 (R-3E) (Lanes 2 and 3). Considering
the comparable amounts of input in each pull-down assay, the
association of wild-type PR8-NS1 with PDlim2 was not as
favorable as wild-type HN12-NS1wt. The mammalian two-hybrid
assays further validated the selectivity of PDlim2 for a Glu residue
in the 23 position, since replacing the 23 Arg with Glu raised the
activity of the reporter promoter to the same level as wild-type
HN12-NS1 (Fig. 3C).
The above in vitro and in vivo assays involving PBM-swapping
mutations in NS1 demonstrated that the 23 position amino acid
residue is a critical site for the binding selectivity of PDlim2.
Structure Determination and Refinement
In order to investigate the mechanism of the interaction
between HN12-NS1 and PDlim2, we first crystallized the native
form of the PDlim2 PDZ domain [34] and chemically synthesized
a hexapeptide (sequence: TIESEV) derived from the C-terminal
of HN12-NS1. Unfortunately, however, we failed to successfully
crystallize the PDZ-peptide complex either by soaking or co-
crystallization. Therefore, following a strategy employed for
solving PDZ-peptide complex structures in several other studies
[19,20], we fused the PDZ domain (1–83) of PDlim2 and the C-
terminal hexapeptide of HN12-NS1 together, as described in
Materials and Methods. This approach yielded crystals in the
space group I23 with unit cell parameters a=b=c=81.9 A ˚,
a=b=c=90u. The complex structure was solved at 2.2 A ˚
resolution using the molecular replacement method. Refinement
of the fusion protein structure resulted in a final model with
crystallographic R-factor (Rcryst) of 0.200 and a free R-factor (Rfree)
of 0.249. Crystallographic statistics are summarized in Table 1 and
Table 2.
Structure of the PDlim2 PDZ domain in complex with the
C-terminal hexapeptide of HN12-NS1
Each asymmetric unit contains one fusion protein with 89
amino acid residues, 47 water molecules and 1 sodium ion. The
final model has good stereochemistry with no amino acid residues
located in disallowed regions of the Ramachandran plot. All side
chains were assigned with the exception of Arg53 and Arg77,
which were not placed due to insufficient electron density.
Experimental structure factors and the coordinates of the final
refined model have been deposited in the Protein Data Bank
(PDB) with accession number 3PDV.
The structure of the PDZ region (1–83) of PDlim2 is consistent
with a classic type I PDZ domain composed of five b-strands (b1–
b5) and three a-helices (a1, a2 and a3), as shown in Fig. 4A. The
five b-strands form an anti-parallel b-sheet with a topological
order of b1-b5-b4-b3-b2. The small a1 helix is localized between
b2 and b3, while a2 lies between b3 and b4, and a3 is situated
between b4 and b5. The three a-helices cap the two open ends of
the partially open b-sheet barrel, with a1 and a3 at the b2 end and
a2 at the b1 end. The interaction site of the PDZ domain is
occupied by the C-terminal HN12-NS1 hexapeptide extension
from a neighbouring PDZ-peptide fusion protein (Fig. 4A and Fig.
S1A).
The detailed mode of interaction between the PDZ domain
of PDlim2 and the C-terminal NS1 hexapeptide extension is
consistent with the classical type I PDZ domain-ligand peptide
interaction mode exhibited by other PDZ-ligand structures solved
using the co-crystallization strategy [35] or the PDZ-ligand fusion
strategy [19,20] as employed in this study (Fig. 4B and Fig. S1B).
Five residues in the C-terminal HN12-NS1 extension peptide
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of the PDZ domain in an anti-parallel manner. In the PDlim2
PDZ domain, the hydrophobic side chains of residues Phe15 and
Ile17 from b2, Ile69 from a3, and the side chain of Trp13
compose a hydrophobic pocket which facilitates packing of the
side chain of the valine residue in position 0 of the HN12-NS1
extension. The residue in the 22 position of the NS1 extension is
recognized by residue His62 (from a3) of the PDZ domain by a
Figure 2. Bifluorescence complementation assay. HeLa cells were co-transfected with constructs encoding the fusion proteins of C- and N-
terminal fragments of YFP as indicated. At 24 h post transfection, cultured cells were kept at room temperature for 4 hours and stained by DAPI and
detected by Confocal laser scanning microscopy. A portion of each transfected cells were analyzed by fluorescence-activated cell sorting (FACS) with
the MFI (mean fluorescence identity) listed in the right column.
doi:10.1371/journal.pone.0019511.g002
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distance of 2.6 A ˚. The two glutamate residues at positions 21
and 23 of the NS1 extension are stabilized via salt bridges with
the positively charged PDZ residues Arg16 and Lys31. No other
obvious interactions can be observed between the NS1 extension
peptide and the PDZ domain.
Characterization of the roles of Arg16 and Lys31 in
PDlim2
To address the importance of the Arg16 and Lys31 residues of
PDlim2 in the interaction between its PDZ domain and HN12-
NS1, we constructed a series of PDlim2 mutations at these two
positions in the PDZ domain and examined their binding abi-
lity with HN12-NS1 or PR8-NS1 by GST pull-down assays, as
described previously (Fig. 5A). The wild-type PDlim2 (WT) showed
the strongest binding to HN12-NS1 (Fig. 5A, lane 1), while the
R16A and K31S mutants exhibited reduced affinity with HN12-
NS1 (Fig. 5A, lane 2 and 3). Furthermore, the ability of the PDlim2
R16A/K31S double mutant to associate with HN12-NS1 was
completely abolished (Fig. 5A, lane 4), reflecting the disruption of
thesaltbridges. Therefore,either one ofthebasic residues(Arg16 or
Figure 3. NS1 mutations and PDlim2 binding analyses. (A) Schematic depiction of NS1 mutations. Wild-type NS1 of the H5N1 subtype
influenza virus (A/Chicken/Henan/12/2004) is annotated as HN12-NS1wt, and NS1 from the H1N1 subtype (A/Puerto Rico/8/34) as PR8-NS1wt (top
two rows). The amino acid in the 23 position of the NS1 PBM was indicated by box. The 23 amino acid swapped to R or E were named as HN12-NS1
(E-3R) or PR8-NS1 (R-3E) respectively (the lower two rows). The PBM deleted mutation of NS1 from the H5N1 subtype was named HN12-NS1DPBM
(last row). (B) The interaction of PDlim2 with HN12-NS1wt, PR8-NS1wt, HN12-NS1 (E-3R) or PR8-NS1 (R-3E) was analyzed by GST-pull down assays, as
described in Experimental Procedures, with GST alone as a control. Elution (top panel) and the amount of input lysate (bottom panel) were performed
by SDS-PAGE and Western blot. The arrows indicated the relevant bands after detected by anti-His or anti-GST antibodies. (C) Mammalian two hybrid
assay. NS1 or its mutations and PDlim2 were constructed into pACT and pBind, respectively. This pair of plasmids, together with pG5luc, were
transfected into HeLa cells. The relative luciferase unit of cell lysates was quantified by the Dual-Luciferase Reporter Assay System (Promega). The
data represent three independent experiments.
doi:10.1371/journal.pone.0019511.g003
Table 1. Data collection statistics.
Parameters Statistics
Space group I23
Unit cell parameters a=b=c=81.9 A ˚, a=b=c=90u
Wavelength (A ˚) 1.5418
Resolution (A ˚) 2.20
Measured reflections 49704
Unique reflections 4769
Completeness (%) 99.8 (100)
a
Rmerge
b 0.062 (0.374)
Redundancy 10.4 (10.4)
I/sI 32.6 (6.2)
aNumbers in brackets refer to the statistical data for the outer resolution shell.
bRmerge=ShSi|Ii (h)2,I( h ) .|/ShSi,Ii (h)., where Ii (h) is the intensity of an
individual measurement of the reflection, and ,Ii (h). is the mean intensity of
the reflection.
doi:10.1371/journal.pone.0019511.t001
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PDlim2 and HN12-NS1 via charge interactions, or the availability
of both positively charged residues would enhance the binding. It is
likely that the contribution of Lys31 to the interaction between
PDlim2and HN12-NS1 is muchgreater than Arg16, as the amount
of the R16A mutant PDlim2 protein pulled down by HN12-NS1
was higher than the K31S mutant (Fig. 5A, lane 2 and 3).
The higher binding of HN12-NS1 by the R16A PDlim2 mu-
tant than by the K31S mutant led us to assume that the R16A
mutation may provide a favorable advantage to the binding,
despite its charge. We therefore mutated Arg16 to a glutamine
residue, which also features a long side chain but is charge free,
and examined its binding affinity to HN12-NS1. The results
showed that the R16Q mutant was unable to bind with the NS1
protein, even though Lys31 was still present in the mutant PDlim2
protein (Fig. 5A, lane 5). These observations imply that Arg16, in
addition to playing a positive role in providing salt bridges for
binding HN12-NS1, may also impose a steric requirement on the
PBM binding. In wild-type PDlim2, the positive effect of Arg16 is
dominant. Lys31 is not as close to the two glutamine residues in
the ESEV PBM (Fig. 4B) and should inflict little or no steric
influence, therefore contributing more than the bi-functional
Arg16 to the interaction between PDlim2 and HN12-NS1.
As shown in Fig. 5B, a sequence alignment of PDlim2 with
selected PDZ domain proteins predicted to bind to the ESEV
PBM of NS1 reveals that all except TIP-1 and the first two PDZ
domains of Scribble have a conserved arginine residue equivalent
to Arg16 of PDlim2. A conserved arginine residue can also be
found in an equivalent position to the basic residue Lys31 of
PDlim2 in all other PDZ domains, with the exception of ENH.
Interaction of NS1 and PDlim2 may not affect NF-kB
activity, nor STAT1 mediated signal transduction -
The discovery of PDlim2 as a new cellular target for HN12-NS1
prompted us to investigate the biological significance of this se-
lective interaction and the mechanism involved in the virulence of
H5N1 influenza viruses. Takashi and colleagues previously
reported that PDlim2 has E3 ligase activity for the p65 subunit
of NF-kB and controls the transcription activity of NF-kB via the
ubiquitination and degradation of p65 [36]. In order to verify
whether NS1 participates in this pathway, we established an
NF-kB reporter assay in HeLa cells co-transfected with plasmids
encoding PDlim2 and wild-type HN12-NS1 or the HN12-
NS1DPBM mutant. When induced by lipopolysaccharides (LPS),
the PDlim2 transfected group showed no inhibition of the reporter
activity (Fig. 6A, lane 4 from the left) in this assay. As reported in a
previous study [3], both the wild-type HN12-NS1 and the HN12-
NS1DPBM mutant transfected groups could suppress the reporter
activity [3] (Fig. 6A, lane 2 and 3 from the left), but there was no
significant difference between them, even if PDlim2 was co-
transfected or not (Fig. 6A, lane 5 and 6 compared with lane 2 and
3). The expression levels of PDlim2 and NS1 detected by Western
blot indicated the homogeneity of transfection in each group. This
result implies that the binding between PDlim2 and HN12-NS1
may not influence the activity of NF-kB.
It was also reported that PDlim2 can impact the tyrosine
phosphorylation of STAT4 or lead to degradation of STAT1
and STAT4 under stimulation [31]. We also examined whether
HN12-NS1 can affect this PDlim2-STAT1 pathway by co-
transfecting PDlim2 with wild type HN12-NS1 or the HN12-
NS1DPBM mutant into HeLa cells. The stimulation of IFN-a
induced a strong phosphorylation of the endogenous STAT1
Figure 4. Structure of the PDlim2 PDZ domain in complex with the HN12-NS1 C-terminal hexapeptide extension. (A) Ribbon diagram
of the PDlim2 PDZ domain (yellow) is from one PDZ-PBM fusion protein. The PBM peptide (green) presented here is from a neighboring PBM-PDZ
fusion protein. (B) Stereo view of the interaction site. Carbon atoms from the PDlim2 PDZ domain and HN12-NS1 C-terminal hexapeptide extension
are colored yellow and green respectively. Nitrogen and oxygen atoms are colored blue and red, respectively. Hydrogen bonds are indicated by red
dashed lines.
doi:10.1371/journal.pone.0019511.g004
Table 2. Structure refinement statistics.
Parameters Statistics
Rcryst
a 0.200
Rfree
b 0.249
Bond rms deviation (A ˚) 0.008
Angle rms deviation (u) 1.187
Average B factor (A ˚2) 27.5
Ramachandran plot (%)
c 98.81/1.19/0
aRcryst=S (||Fobs|2|Fcalc||) / S|Fobs|, where Fobs and Fcalc are the observed and
calculated structure-factor amplitudes, respectively.
bRfree was calculated as Rcryst using the reflections in a test set not used for
structure refinement, which is a randomly selected subset containing 4.5% of
unique reflections.
cCalculated using MolProbity. Numbers reflect the percentage of residues in the
preferred, allowed, and disallowed regions, respectively.
doi:10.1371/journal.pone.0019511.t002
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However, compared to previously reported data [7,18], the
levels of STAT1 phosphorylation in our experiments were similar
in the presence of wild-type HN12-NS1 and HN12-NS1DPBM
in combination with PDlim2. These results suggest that the
interaction between NS1 and STAT1 may be complicated and
further studies are required to clarify the function of the
interaction between NS1 and PDlim2 in interferon-induced
STAT1 signaling.
Discussion
The NS1 PBM bearing the sequence ESEV (NS1-ESEV) has
been found in highly virulent human virus strains from the 2003–
2004 outbreak in Hong Kong, Vietnam, and Thailand, while NS1
PBMbearing the sequenceRSKV (NS1-RSKV) were usually found
in milder human viruses [10]. Intensive studies have demonstrated
the multiple roles of influenza virus NS1 in anti-host immune
responses, such as interfering in RIG-I pathways to interrupt
interferon production [4], and inhibiting PKR and OAS [5,6] to
halt host protein synthesis. The mechanisms that distinguish the
HPAI NS1 PDZ binding motifs (ESEV) from the other human
influenza virus strains (RSEV or RSKV) were not understood until
the interaction between NS1 and Scribble was reported to regulate
cell apoptosis during influenza virus infection. In a recent study, the
PDZ domain protein Scribble was demonstrated to selectively
interact with NS1 bearing an ESEV PBM via its first two PDZ
domains [37]. Other PDZ domain proteins including MAGI-1, -2,
-3 and Dlg-1 were also found to interact with NS1 proteins bearing
ESEV-like PBM [18,37]. In this report, we performed yeast two-
hybrid screening, originally aiming to find potential target(s) of
Avian Influenza virus NS1 that functions in the immune responses.
Considering that human spleen is rich in macrophage, antigen
presenting cells, and lymphocytes, we therefore choose human
spleen cDNA library andusing full-lengthwild type HN12-NS1and
a human PR8-NS1 as baits respectively, rather than using ESEV or
Figure 5. Analysis of the binding interface between PDlim2 and HN12-NS1. (A) GST pull-down assay. PDlim2 and its mutations were His-
tagged and expressed in E. coli. GST- HN12-NS1 or PR8-NS1 were linked to GST agarose beads, which were added to E. coli expressed His-PDlim2 or its
mutations and incubated for 2 h. The pellets were washed and eluted by boiling. The elution was then subjected to SDS-PAGE and Western blot
analysis. (B) Sequence alignment of PDZ domains from different proteins. Scrib-PDZ1 and Scrib-PDZ2 refer to the first and second PDZ domain of
Scribble. Conserved residues are written in bold letters, and the identical ones are highlighted with gray background. Basic residues equivalent to
Arg16 or Lys31 of PDlim2 are highlighted with black background and the sites are indicated with arrows. Sequences were aligned by the ClustalX
program, and the alignment was drawn using the online ESPript server (http:// espript.ibcp.fr/).
doi:10.1371/journal.pone.0019511.g005
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ubiquitously expressed in other tissues as well, PDlim2 is the only
one that is highly expressed in lungs [30,31]. Interestingly, PDlim2
contains a PDZ domain and exhibits PBM selectivity towards
HN12-NS1 (ESEV) over PR8-NS1 (RSEV), leading us to speculate
that PDlim2 is a possible cellular target for HN12-NS1 (ESEV).
Further investigation is ongoing to understand the biological
relevance of the interaction between PDlim2 and HN12-NS1
(ESEV).
PDZ domains exist in numerous proteins as structural scaffolds,
linking the biological activities of the other functional domains.
PDlim2 recruits p65 of NF-kB to the Lim ubiquitin ligase activity
[36]. The NS1 proteins of many HPAI strains differ from those
isolated from milder strains by a single amino acid in their
canonical PDZ binding motifs. We established that PDlim2 is able
to distinguish NS1 proteins from different influenza virus strains
and binds selectively to the NS1 protein encoded by a highly
pathogenic H5N1 avian influenza virus, HN12-NS1. As PDlim2
contains only one PDZ domain, it can be considered as a good
model to investigate the binding mechanism between PDZ
domains and the NS1 PBM. Our crystal structure reveals that
the charge interactions between PDlim2 and HN12-NS1 are
crucial for their binding interaction. In PR8-NS1, the 23 position
amino acid residue is an arginine, a positively charged residue with
a long side chain. This residue is expected to be unable to form a
salt bridge with either of the two basic residues (Arg16 and Lys31)
in the PDlim2 PDZ domain. Furthermore, the arginine residue in
the 23 position of the PR8-NS1 PBM can inflict strong charge
repulsion with Arg16 and Lys31 in the PDZ domain of PDlim2,
severely compromising the binding between the RSEV PBM and
the PDlim2 PDZ domain. The K31S or R16A mutants of PDlim2,
which already preclude the steric influence caused by Arg16, also
exhibit no binding affinity with PR8-NS1 (Fig. 5A). Although
the 21 position glutamate residue in RSEV should have been able
to form salt bridges with Arg16 or Lys31, the charge repulsion
between the 23 position arginine residue of the RSEV PBM and
either the Arg16 or Lys31 residue of PDlim2 was implied to be
sufficient to disrupt the PDlim2-NS1 interaction. The PDlim2
R16A/K31S double mutant, which failed to stabilize residues in
the 21 and 23 positions in the ESEV PBM, should also be unable
to stabilize residues in the 21 and 23 positions in the RSEV
PBM, which is consistent with the lack of binding observed with
PR8-NS1 (Fig. 5A, lane 4).
In human influenza viruses, NS1 proteins bearing RSKV or
KSEV PBM have also been identified [10]. In the case of
PDlim2, the RSKV PBM contains not only the 23p o s i t i o n
arginine residue, but also another basic amino acid in the 21
position. Based on our above analysis, it is reasonable to consider
that this PBM should be unable to bind with the PDZ domain of
PDlim2. As we were able to detect only trace amounts of wild-
type PR8-NS1 binding with PDlim2, the RSKV PBM would be
expected to have even lower affinity than the RSEV PBM. In the
case of the KSEV PBM, the residue in the 23p o s i t i o ni s
positively charged and should exhibit slightly higher affinity with
PDlim2 than the RSEV PBM, although the interaction would still
be considerably weaker than for the ESEV PBM. Although the
arginine residue in the 23 position has a side chain even longer
than that of lysine, the Cd,N e,C f,N g1, and Ng2 atoms must lie
in the same plane, and thus its flexibility is considerably lower
than the side chain of lysine. When interacting with the PDZ
domain, the flexible lysine residue in KSEV may be driven to a
position that minimizes the charge repulsion. Based on the above
analyses, we would expect to rank the NS1 PBM in terms of
their binding abilities to PDlim2 as follows: ESEV.KSEV.
RSEV.RSKV. In studies by Jackson and colleagues, recombi-
nant influenza viruses differing only in their NS1 PBMs were
used to infect mice and the mean lethal dose (MLD50)w a s
measured. The virulence of the viruses, ranked in decreasing
order of MLD50 (from large to small), were viruses bearing the
ESEV, EPEV, KSEV, and RSKV PBM [14]. A recombinant
virus in which the PBM was truncated showed the lowest
virulence. Interestingly, the virulence of the recombinant viruses
bearing the above PBMs is consistent with the binding abilities of
Figure 6. Effects of the PDlim2 and HN12-NS1 interaction on
NF-kB activity or STAT1 phosphorylation. (A) HeLa cells was
transfected with the reporter plasmid pNF-kB-luc and ptk-RL, together
with the indicated plasmids. After 24-hour post-transfection, cells were
stimulated by LPS (10 mg/ml) for 5 hours. Cells were harvested and
firefly and renilla fluorescence unit were measured by luminomitor. The
relative luciferase activity (Y-axis)=the unit of firefly luciferase activity /
the unit of Renilla luciferase activity (to indicat transfection efficiency,
and is presented as the mean calculated from three independent
experiments. The expression of NS1 and PDlim2 were analyzed by
Western blot with indicated antibodies (lower panels). (B) HeLa cells
were transfected with the combination of the plasmids as indicated at
the top of the figure and treated by IFN-a at 50 U/ml for 4 hours. The
cell lysates were analyzed by SDS-PAGE and Western blot, with
antibodies specific for phosphorylated STAT1, STAT1, HA-tag, Flag-
tag, and GAPDH as loading control.
doi:10.1371/journal.pone.0019511.g006
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PDZ binding motif, although it has been reported to bind with
certain PDZ domains, such as the PDZ domain of Dsh [10]. As
EPEV also contains the same two acidic glutamate residues as
ESEV, we speculate that these two glutamates in EPEV should
also be able to interact with the two basic residues in the PDZ
domain, although the proline residue in the 22 position is
expected to alter the conformation of the PBM and subsequently
reduce the affinity of the interaction. Jackson and colleagues
further showed that human influenza viruses containing the three
most virulent NS1 PBMs (ESEV, EPEV, and KSEV) correspond
to the highly virulent strains discovered from the 2003–2004
outbreak in Hong Kong, Vietnam, and Thailand; the 1997–1999
outbreaks in Hong Kong; and the 1918 ‘‘Spanish flu’’ outbreak,
respectively [10]. In contrast, influenza viruses containing the
RSEV or RSKV PBMs, which were speculated to exhibit barely
detectable binding with PDlim2, have not been associated with
large influenza outbreaks nor with high pathogenicity. However,
in other studies, evidence has indicated that there were minor
differences between the ESEV, RSEV or truncated PBM NS1
proteins in the control of its nuclear migration and mean lethal
dose in infected cells [16]; the human C-terminal RSKV PBM
was found to increase viral replication in human and ducks, while
the avian C-terminal ESEV PBM increased virulence in mice
[15]. Furthermore, the nucleic acid region of the influenza virus
that encodes the PBM of NS1 also participates in encoding
another protein, NEP, via a different reading frame [14]. The
above findings suggest that the relationship between the sequence
variation in the PBM and the virulence of influenza virus is
complicated and requires further investigation. The selective
binding by NS1 of PDZ containing proteins, such as PDlim2,
may provide a key starting point for future studies of the
pathogenic mechanism and virulence determining factors of
influenza viruses.
Duringthecourse ofanalysis,a protein calledScribble containing
four PDZ domains was reported to be involved in an NS1-mediated
anti-apoptosis process during influenza virus infection. This protein
was also reported to bind with only the ESEV PBM, but not the
RSKV PBM, via its first two PDZ domains [17]. We compared the
sequences of the two PDZ domains of Scribble with the PDZ
domain of PDlim2 and observed that each of the first two PDZ
domains of Scribble has a basic residue equivalent to Lys31 of
PDlim2 (Fig. 5B). Although each of the first two Scribble PDZ
domains lacks a basic residue equivalent to Arg16 of PDlim2, the
Ser residues may allow the special selectivity to the NS1 (ESEV). In
the study by Obenauer and colleagues, TIP-1 was also in the list of
potential ESEV PBM binding proteins [10]. Comparing the
structures of TIP-1 [35] and our structure of the PDlim2 PDZ
domain, TIP-1 also contains an equivalent basic residue (Arg59) to
the Lys31 residue of PDlim2, but lacks the other basic residue
equivalent to the Arg16 residue of PDlim2. Thus, TIP-1 could be
considered as another ‘‘PDlim2-like’’ PDZ domain containing
protein. Besides PDlim2, there are a series of human PDZ and LIM
domain containing proteins, including actinin-associated LIM
protein (ALP, PDlim3), Elfin (CLP36, PDlim1), Enigma (LMP-1,
PDlim7), Enigma homologue (ENH, PDlim5), reversion-induced
LIM protein (RIL, PDlim4), and Z-band associated protein (ZASP,
Cypher, Oracle, PDlim6) [38]. A sequence alignment revealed that
the equivalent residue to Arg16 of PDlim2 is strictly conserved in all
of these proteins (Fig. 5B). Theoretically, these proteins should favor
ESEV PBM over RSEV or RSKV PBM, and thus be possible
targets of HPAI NS1. However, the physiological associationshould
also be attested for deciphering the role of the NS1 PBM in
determining the virulence of the influenza virus.
The importance of PDlim2 in host innate immune responses has
been recognized recently but not fully investigated. A study by
Tanaka and colleagues revealed the significant roles of PDlim2,
as an E3 ubiquitin ligase, in terminating NF-kB activation through
intranuclear sequestration and subsequent degradation [36].
However, in our reporter assay, equal suppression of NF-kB was
seen in cells transfected with HN12-NS1wt and the HN12-
NS1DPBM mutant (Fig. 6A), or in cells infected with influenza
viruses lacking the ESEV PBM [39]. Thus, it is likely that the
effect on NF-kB by NS1 is independent of its PDZ binding.
Transfected NS1 was reported to downregulate the phosphor-
ylation of STAT1 under IFN stimulation [7,18]. However, in all of
our repeated experiments, wild-type HN12-NS1 did not exhibit a
marked impact on the IFN-induced phosphorylation of STAT-1
(Fig. 6B). We cannot rule out the possibility that the effect of the
NS1-PDlim2 interaction on interferon-STAT1 signaling is strain-
specific, as the NS1 of the influenza A virus we employed is dif-
ferent from the strains used in other studies [7,18]. Although close
inspection shows that a slightly lower level of STAT-1 phosphor-
ylation could be detected in the wild-type HN12-NS1 transfected
group (Fig. 6B, lane 3), it is not evident enough to be used as a
readout. In addition, transfected NS1 may behave differently
from the NS1 in cells infected with influenza virus or recombinant
variants by reverse genetic modifications [40]. Due to stringent
biological safety restrictions in mainland China, we were unable to
test with recombinant viruses containing a H5N1 NS1 fragment.
The discrepancy between transiently expressed NS1 and NS1 in
infected cells may be more-or-less attributed to the output.
We reported here the structural characteristics of NS1 PBM
with a PDZ-containing protein, PDlim2, and this feature and
selectivity may be applied to a broader range of PDZ-containing
target for the NS1 in Avian influenza virus. The biological effects
of NS1 (ESEV) mediated by PDlim2 are to be explored along with
a further understanding of the function of PDlim2, as well as
efficient and available approaches to analyze the effects of NS1 in
more physiological circumstances.
Supporting Information
Figure S1 Structure of the PDlim2 PDZ domain fused
with the HN12-NS1 C-terminal hexapeptide, and the
comparison with similar structures. (A) Ribbon diagram of
two adjacent PDlim2 PDZ-hexapeptide fusion proteins. (B)
Superposition of PDZ-ligand complex structures. The structure
of PDlim2 PDZ domain in complex with its HN12-NS1 C-
terminal hexapeptide ligand is shown in yellow. The structure of
the first PDZ domain of the Na
+/H
+ exchanger regulatory factor
in complex with a pentapeptide ligand from the carboxyl-terminal
of the b2 adrenergic receptor (PDB code: 1GQ4) or cystic fibrosis
transmembrane conductance regulator (PDB code: 1I92) or
platelet-derived growth factor receptor (PDB code: 1GQ5) is
showed in red, green, or blue, respectively. The structure of TIP-1
in complex with c-terminal hexapeptide of Kir2.3 is shown in
magentas. Secondary structures are only assigned to the ligand
peptides.
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